1. Home
  2. PRPO vs CISS Comparison

PRPO vs CISS Comparison

Compare PRPO & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • CISS
  • Stock Information
  • Founded
  • PRPO N/A
  • CISS 2022
  • Country
  • PRPO United States
  • CISS Greece
  • Employees
  • PRPO N/A
  • CISS N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • CISS Marine Transportation
  • Sector
  • PRPO Industrials
  • CISS Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • CISS Nasdaq
  • Market Cap
  • PRPO 8.8M
  • CISS 8.1M
  • IPO Year
  • PRPO N/A
  • CISS N/A
  • Fundamental
  • Price
  • PRPO $5.50
  • CISS $1.47
  • Analyst Decision
  • PRPO
  • CISS
  • Analyst Count
  • PRPO 0
  • CISS 0
  • Target Price
  • PRPO N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • PRPO 8.8K
  • CISS 448.4K
  • Earning Date
  • PRPO 08-15-2024
  • CISS 08-30-2024
  • Dividend Yield
  • PRPO N/A
  • CISS N/A
  • EPS Growth
  • PRPO N/A
  • CISS N/A
  • EPS
  • PRPO N/A
  • CISS 48.19
  • Revenue
  • PRPO $15,812,000.00
  • CISS $38,379,148.00
  • Revenue This Year
  • PRPO $75.18
  • CISS N/A
  • Revenue Next Year
  • PRPO N/A
  • CISS N/A
  • P/E Ratio
  • PRPO N/A
  • CISS $0.03
  • Revenue Growth
  • PRPO 61.64
  • CISS N/A
  • 52 Week Low
  • PRPO $4.31
  • CISS $1.11
  • 52 Week High
  • PRPO $8.99
  • CISS $87.00
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 56.91
  • CISS 50.99
  • Support Level
  • PRPO $4.32
  • CISS $1.35
  • Resistance Level
  • PRPO $5.12
  • CISS $1.47
  • Average True Range (ATR)
  • PRPO 0.42
  • CISS 0.08
  • MACD
  • PRPO 0.04
  • CISS 0.03
  • Stochastic Oscillator
  • PRPO 79.87
  • CISS 89.43

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: